EUVIMEDEUVIMED entdecken
Crossref

Kinetic Modeling and Parametric Imaging of 13 N-NH 3 in Treatment-Naïve Lung Cancer

Hui Yuan, Fanghu Wang, Yang Chen, Xiaoqiang Pan, Qing Zhang, Tao Sun, Lei Jiang iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Hui Yuan und 6 weiteren Autor:innen. Beteiligte Einrichtung: PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical Universi…. Hauptthemen laut MEDLINE: Lung Neoplasms, Nitrogen Radioisotopes. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Guangdong Provincial People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

13N-NH3 PET imaging provides insights into tumor perfusion and metabolism, hence potentially valuable in oncological diagnosis, staging, and prognosis. However, its in vivo kinetic characteristics and the optimal protocol for kinetic modeling and parametric imaging remain unclear. This study aims to elucidate the kinetic features of 13N-NH3 in lung cancer and its clinical value. Nine lung cancer surgical candidates were prospectively incorporated. Using total-body PET/CT scanner, 35 min 13N-NH3 acquisitions were conducted immediately postinjection. Subsequently, routine 5 min 18F-FDG acquisitions were made. 13N-NH3 PET data were reconstructed into dynamic image series. Tumor lesions and normal organs were segmented using nonthreshold dependent automatic or semiautomatic tools. Reversible and irreversible 2-tissue compartment models (2TC vs 2TiC) using image-derived input functions (IDIFs) with population-based metabolite correction were adopted for parametric modeling. Akaike Information Criterion (AIC) was calculated for model selection. Parametric images were produced with the optimal model for lesions. A total of 9 patients presented with 9 primary lung tumors and 17 histologically confirmed lymphadenopathy. All primary lung tumors and regional lymph node metastases were detectable using both 13N-NH3 and 18F-FDG imaging. Primary lung tumors, regional lymphadenopathy, and lung backgrounds demonstrated smaller AIC using 2TC models with pulmonary artery as IDIF, while other organs favored either 2TC or 2TiC models with the descending aorta as IDIF. Lesion-to-background lung ratios reached around 2.218-3.407 for primary lung tumors and 1.932-2.537 for regional lymphadenopathy 10-20 min postinjection of 13N-NH3. Vt images derived from 2TC modeling showed better lesion-to-background lung ratios (4.511 ± 2.955 for primary tumor, and 2.991 ± 2.152 for regional lymphadenopathy). For 13N-NH3 imaging in lung cancer, a static image can be acquired at 10-20 min postinjection for clinical diagnosis. The reversible 2TC model is preferred over 2TiC, and the Vt image is preferred over other parametric images in terms of lesion contrast.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsNitrogen RadioisotopesHumansFemaleMaleMiddle AgedAgedPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18KineticsRadiopharmaceuticalsProspective StudiesPositron-Emission Tomography

Stichwörter der Autor:innen

13N-NH3dynamic imagingkinetic modelinglung cancer

Substanzen

Fluorodeoxyglucose F18RadiopharmaceuticalsNitrogen Radioisotopes

Autor:innen und Institutionen

  • PET Center, Department of Nuclear Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou 510080, China.
  • Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen 518055, China.

ORCID-Profile: Lei Jiang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Guangdong Provincial People's Hospital

Zitieren

APA

Yuan, H., Wang, F., Chen, Y., Pan, X., Zhang, Q., Sun, T., & Jiang, L. (2025). Kinetic Modeling and Parametric Imaging of 13 N-NH 3 in Treatment-Naïve Lung Cancer. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00602

Vancouver

Yuan H, Wang F, Chen Y, Pan X, Zhang Q, Sun T, et al. Kinetic Modeling and Parametric Imaging of 13 N-NH 3 in Treatment-Naïve Lung Cancer. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00602

BibTeX
@article{Yuan2025,
  author = {Yuan, Hui and Wang, Fanghu and Chen, Yang and Pan, Xiaoqiang and Zhang, Qing and Sun, Tao and Jiang, Lei},
  title = {Kinetic Modeling and Parametric Imaging of 13 N-NH 3 in Treatment-Naïve Lung Cancer},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00602}
}
Kostenlos starten →